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Abstract
Background: To date, little is known about the initial spread and response to the 2009 pandemic of novel influenza A
(‘‘2009 H1N1’’) in tropical countries. Here, we analyse the early progression of the epidemic from 26 May 2009 until the
establishment of community transmission in the second half of July 2009 in Ho Chi Minh City (HCMC), Vietnam. In addition,
we present detailed systematic viral clearance data on 292 isolated and treated patients and the first three cases of selection
of resistant virus during treatment in Vietnam.
Methods and Findings: Data sources included all available health reports from the Ministry of Health and relevant health
authorities as well as clinical and laboratory data from the first confirmed cases isolated at the Hospital for Tropical Diseases
in HCMC. Extensive reverse transcription (RT)-PCR diagnostics on serial samples, viral culture, neuraminidase-inhibition
testing, and sequencing were performed on a subset of 2009 H1N1 confirmed cases. Virological (PCR status, shedding) and
epidemiological (incidence, isolation, discharge) data were combined to reconstruct the initial outbreak and the
establishment of community transmission. From 27 April to 24 July 2009, approximately 760,000 passengers who entered
HCMC on international flights were screened at the airport by a body temperature scan and symptom questionnaire.
Approximately 0.15% of incoming passengers were intercepted, 200 of whom tested positive for 2009 H1N1 by RT-PCR. An
additional 121 out of 169 nontravelers tested positive after self-reporting or contact tracing. These 321 patients spent 79%
of their PCR-positive days in isolation; 60% of PCR-positive days were spent treated and in isolation. Influenza-like illness was
noted in 61% of patients and no patients experienced pneumonia or severe outcomes. Viral clearance times were similar
among patient groups with differing time intervals from illness onset to treatment, with estimated median clearance times
between 2.6 and 2.8 d post-treatment for illness-to-treatment intervals of 1–4 d, and 2.0 d (95% confidence interval 1.5–2.5)
when treatment was started on the first day of illness.
Conclusions: The patients described here represent a cross-section of infected individuals that were identified by
temperature screening and symptom questionnaires at the airport, as well as mildly symptomatic to moderately ill patients
who self-reported to hospitals. Data are observational and, although they are suggestive, it is not possible to be certain
whether the containment efforts delayed community transmission in Vietnam. Viral clearance data assessed by RT-PCR
showed a rapid therapeutic response to oseltamivir.
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Vietnam reported its first case of infection with 2009 pandemic
influenza virus A (H1N1) on 31 May 2009, in a Vietnamese
student returning from Wisconsin (United States) who had arrived
at the international airport of Ho Chi Minh City (HCMC) on 26
May 2009. 12 d later on 12 June, Hanoi reported its first cases.
When the World Health Organization (WHO) declared pandemic
phase 4 on 27 April 2009, the Vietnamese Ministry of Health
mandated airport body temperature scans and symptom ques-
tionnaire screening of arriving international travelers and in-
hospital isolation of suspected cases, ensuring that symptomatic
passengers were intercepted, transferred to a hospital, screened by
reverse transcription (RT)-PCR, and treated if positive. At that
time, the Pasteur Institute and the Hospital for Tropical Diseases
(HTD) were the only two laboratories performing the WHO/US
Centers for Disease Control (USCDC) influenza virus A RT-PCR
in HCMC. Both labs received specific primers for the novel virus
by the second week of May, and after that point the Pasteur
Institute provided formal national diagnostic confirmation of 2009
H1N1 infection. After 29 May, HTD served as the main referral
centre for confirmed 2009 pandemic influenza treatment within
the city, including cases identified from airport interceptions and
community outbreaks. Passengers testing positive were transferred
to HTD, where they were isolated, treated with oseltamivir, and
followed up clinically for at least 5 d and until RT-PCR negative.
Here we review available virological and epidemiological data
of pandemic influenza importation and transmission in HCMC
from 26 May to 24 July 2009. During this period, HTD had
responsibility for clinical follow-up of cases diagnosed by the
Pasteur Institute, and for primary diagnosis of suspected patients
reporting to our outpatient clinics or transferred from other
hospitals/clinics. We describe the epidemiological, clinical, and
viral clearance characteristics of cases of 2009 pandemic influenza
during this early phase of containment and the establishment of
community transmission, and discuss implications and forecasts for
the progression of the outbreak.
For brevity, hereafter we use the term ‘‘2009 H1N1’’ to refer to
the virus and the disease caused by the novel influenza virus A/
H1N1/2009 that was identified in Mexico and the United States
in late April 2009. Data on clearance of viral RNA and viable
virus were reported previously on ProMED-mail [1–3].
Methods
Data Sources
Data sources included the first 30 reports on the 2009 H1N1
response from the Health Services of HCMC [4], dating from 10
May to 9 July 2009, as well as comprehensive clinical and
diagnostic information for the first 300 2009 H1N1-confirmed
patients admitted to HTD, between 29 May and 25 July 2009.
Eight of 300 patients were excluded from clinical and virological
analysis because of missing test results. The Health Services
reports provided information regarding (i) the daily numbers of
incoming air travel passengers arriving at HCMC airport; (ii)
numbers of persons isolated; (iii) diagnostic results and isolation
status of intercepted travelers; and (iv) reporting and diagnostic
confirmation of 2009 H1N1 from patients voluntarily presenting
to all other health care facilities in the city. Data from HTD
diagnostics and HCMC Health Services reports were combined
into a final dataset comprising 321 PCR-positive individuals and
298 PCR-negative individuals. Vietnam’s Ministry of Health
reported 424 molecular confirmations of 2009 H1N1 between 31
May and 25 July 2009 in southern Vietnam; our dataset represents
321 (76%) of these cases, making it representative of the total
known case burden of 2009 H1N1 in southern Vietnam during
these 8 wk (Figure 1).
Patient Samples and Clinical Data
Upon molecular confirmation of 2009 H1N1, all patients were
admitted to the HTD isolation ward and treated with 75 mg
oseltamivir twice a day for 5 d. Initial data on symptoms were
collected, chest X-rays and ECGs performed, blood specimens
collected for hematology and biochemistry, and respiratory
specimens collected for RT-PCR. Patients admitted between 29
May and 29 June 2009 were tested daily by RT-PCR until
negative. From 30 June to 16 July 2009, the sampling schedule for
RT-PCR diagnostics was modified to reduce the workload of the
hospital laboratory; respiratory sampling for RT-PCR was limited
to the day of admission and day 5 after admission. Starting on 17
July 2009, the sampling schedule was again modified to include
day 3 respiratory specimens, with the objective of facilitating early
discharge of PCR-negative patients. Patients still positive after 5 d
received an additional 5-d course of oseltamivir (n=18) and were
sampled daily until PCR-negative. One patient received 5 d of
Figure 1. New cases as reported by the Ministry of Health and Hospital for Tropical Diseases. Day-by-day comparison of official H1N1
confirmations in southern Vietnam as reported by the Ministry of Health in Vietnam (dark gray bars) and by the surveillance and diagnostics
laboratories of HTD/Oxford University Clinical Research Unit (OUCRU) and the HCMC Health Services (red bars) during the initial epidemic phase in
HCMC. Overall, 321 H1N1 confirmations were captured by HTD, OUCRU, and the HCMC Health Services, out of a total of 424 reported for southern
Vietnam during the period from 31 May to 25 July 2009. HTD confirmations are a subset of Ministry of Health confirmations; reporting dates for
individual cases can differ.
doi:10.1371/journal.pmed.1000277.g001
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vast majority of respiratory specimens were combined nasal and
throat swabs in viral transport medium, however, small numbers
of throat swabs, nasopharyngeal aspirates, sputum, and rectal
swabs were also received and processed.
Molecular Diagnostics
Real-time RT-PCR diagnostics were conducted using protocols
designed and distributed by WHO/USCDC for detection of
influenza A (InfVA) and swine influenza A (swInfVA) viruses [5].
An additional in-house protocol (swH1) was used to confirm 2009
H1N1 using oligonucleotides designed on the basis of the first eight
available 2009 H1N1 sequences, targeting the haemagglutinin
(HA) gene (forward, AGC TAA RAA ACA ATG CCA ARG AA;
reverse, TGC ACG TGT YAT CRC ATT TG; probe, 6-Fam-
TGG AAA YGG CTG CTT TGA ATT YTA YC-BHQ).
Reaction mix and thermocycling protocol for this PCR were the
same as for the WHO/USCDC assays. These in-house primer
sequences provided an improved match with circulating 2009
H1N1 isolates compared to those initially distributed by WHO/
USCDC (unpublished data). Analytical sensitivities of the InfVA,
swInfVA, and swH1 PCRs were in the order of magnitude of 5,
50, and 50 copies/assay, respectively. Specimens collected were
processed for all three targets. Viral clearance analysis was
performed using only the universal InfVA assay, as this was found
to be the most sensitive of the three PCRs (unpublished data).
Selected 2009 H1N1-positive samples with sufficient viral load
(Ct value,38) were screened for the presence of the oseltamivir
resistance–associated mutation H275Y in the neuraminidase (NA)
gene by an in-house real-time RT-PCR protocol using two reverse
primers with a 39 locked nucleic acid (LNA) residue that either
hybridizes with the wild-type or mutant allele and a TaqMan
probe (forward, TAGAAAAGGGAAAGATAGTCAAA; reverse
Wt, ACAGGAGCATTCCTCATAGTG; reverse M, ACAG-
GAGCATTCCTCATAGTA; probe, FAM-CAGTCGAAAT-
GAATGCCCCTAATTA-BHQ1, unpublished data), followed
by confirmatory partial sequencing of NA directly on clinical
specimens or on isolated virus using primers described previously
[6]. Analytical sensitivity of this PCR was 100 copies/assay.
Phenotypic screening for oseltamivir resistance was also conducted
on selected virus isolates, using the fluorogenic substrate
MUNANA as previously described [7,8].
Virus culture was conducted using MDCK-Siat1 cells (kindly
made available by Mikhail Matrosovich) [9], in a six-well plate
format with a maximum of three passage attempts per specimen.
Duration of PCR Positivity
Because not all patients were tested daily, each patient’s
duration of PCR positivity corresponds to an interval-censored
observation defined by that patient’s last positive PCR result and
the first negative PCR result (minus one day). We used a
parametric logistic survival model and maximum likelihood (ML)
estimation to estimate the distribution of a patients’ duration of
PCR positivity. The logistic model was chosen as it provided a
better fit, in terms of the Akaike information criterion, than
Weibull, lognormal, or log-logistic distributions.
Imputation of Missing Data
Epidemiological analysis was carried out on a combined dataset
of 321 PCR-positive patients representing the symptomatic cases
diagnosed in HCMC between 26 May and 24 July 2009. For each
patient, day of hospital admission and recent travel status were
known, making it possible to infer if a patient was infected abroad
or in Vietnam. Other relevant data for these patients were date of
arrival into HCMC, date of admission to hospital, date of illness
onset, date of treatment commencement, reported date of last
positive PCR, and first negative PCR. Missing data included 145
dates of arrival at HCMC International Airport, 29 dates of illness
onset, 29 dates of treatment commencement, 41 dates of reported
first negative PCR result, 29 dates of reported last positive PCR
result. It appears most plausible to us that missing data are due to
purely administrative omissions (a failure to record the respective
information in the patients’ file), i.e., these data are missing
completely at random (MCAR). Dates of arrival, illness onset, and
treatment commencement were imputed as follows. Date of arrival
was imputed on the basis of the empirical distribution of the
arrival-to-admission time interval for the travelers for whom it was
known. Date of illness onset was imputed on the basis of observed
illness-to-admission interval for travelers and residents separately.
Date of treatment commencement was imputed on the basis of the
admission-to-treatment interval. Finally, we imputed the true
duration of PCR positivity (i.e., assuming ideal daily PCR tests) on
the basis of the maximum-likelihood inferred logistic distribution
conditioned on the patient’s reported last positive PCR result, first
negative PCR result (if available), and the interval of time between
illness onset and treatment initiation. We used multiple imputa-
tion, and results are reported as 95% ranges (i.e., 2.5%–97.5%
quantiles from imputed data [QID]) on the basis of 100 randomly
imputed datasets.
Results
Epidemiology
From 27 April through 9 July 2009, a total of 630,778
passengers entered HCMC on international flights; 361,143 of
these coming from countries, either directly or transiting, that had
confirmed cases of 2009 H1N1. Of these travelers, 967 (0.15%)
were intercepted by airport screening procedures—body temper-
ature scan and symptom questionnaire—as febrile and potentially
infected. Individual patient diagnostic data are available for 450
passengers intercepted between 27 April and 24 July 2009. Of
these 450, 200 (44%) tested positive by RT-PCR for 2009 H1N1.
An additional 169 residents of HCMC—defined here as
individuals who were neither intercepted at the airport nor
followed up a few days after arriving in Vietnam from abroad—
were tested after contact tracing or self-reporting to city hospitals
with influenza-like symptoms, and 121 (72%) of these were PCR-
positive for 2009 H1N1. Table 1 presents a summary of these
data; the two datasets do not overlap perfectly as the last available
HCMC Health Services report was dated 9 July 2009.
A summary of these 619 individuals documented by the HCMC
Health Services and HTD from 9 May through 24 July 2009 is
presented in Figure 2. The epidemic in Vietnam has subsequently
continued with 10,568 confirmed cases by 28 October 2009, after
which either the epidemic or case confirmations, or both, slowed
down; 53 deaths and 11,104 cases of 2009 H1N1 were confirmed
as of 28 December 2009. Figure 2 is presented similarly to a
stacked bar graph, such that the height of each colored area
represents the number of individuals with a given infection status
at each point in time. We estimated the numbers of infectious
individuals circulating in the community (red area) on the basis of
the self-reported date of illness onset, and the assumption that
patients were infectious from onset of illness. Although human
influenza infections typically exhibit a presymptomatic infectious
period of 1–2 d [10], we did not include this feature in our
epidemiological analysis as we had almost no data on the
presymptomatic period in our patient group; an individual is
counted as potentially infectious if he is symptomatic or PCR-
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PCR-positive case days were spent in isolation (95% QID 77.9%–
79.9%), and 59.9% of PCR-positive case days (95% QID 58.9%–
61.1%) were spent under isolation and treatment, assuming equal
infectiousness for each day of illness or PCR positivity,
corresponding approximately to a 2-fold or higher reduction of
the infectious capability of these individuals, depending on the
presymptomatic infectious period. The estimate of the proportion
of infectious time spent under isolation is an upper bound, since
undetected cases were not isolated. The outbreak response was
more effective against travelers than residents, presumably because
of active screening at the airport; travelers spent 10.1% of their
potential infectious time circulating in the community (and
possibly transmitting) as opposed to residents who spent 42.2%
of their potentially infectious days circulating in the community.
As not all patients with symptoms self-report or are intercepted,
and as not all patients with mild respiratory illness are tested, the
321 patients described here are an underestimation of the total
burden of infection and community transmission during this time.
The basic reproductive number (R0) of the outbreak in HCMC
can be calculated from the 14-d period from 7 July to 20 July
2009, which appears to be the initial exponential increase of
community transmission. Poisson regression (number of cases
versus time) on these 14 data points gives a rate of exponential
increase r=0.289 (95% confidence interval [CI] 0.248–0.333),
which gives R0=1.5 (95% CI 1.5–1.6) for a generation interval of
1.9 d [11], R0=1.8 (95% CI 1.6–1.9) for a generation interval of
2.6 d [12], and R0=2.0 (95% CI 1.9–2.2) for a generation interval
of 3.6 d [13]. R0 values here are computed using the equation
R0=1+rTc, which assumes an exponential distribution for the
generation time Tc [14]. Confidence intervals must be interpreted
with caution as the 14 data points entered into the regression
analysis are highly nonindependent. This R0 estimate for HCMC
is in the range of estimates obtained from other densely populated
areas for the current pandemic [11,15], but uncertainty whether
the reporting process changed during that period, the small
number of data points, and our lack of an endogenous generation
time estimate mean that much work remains to be done to
understand the basic reproductive number of 2009 H1N1 in
Vietnam.
The first case of sporadic community transmission was reported
on 5 June 2009, eventually followed by two large outbreaks in
schools in the third week of July. Community transmission
probably became fully established by mid-July, as indicated by
the growing numbers of patients presenting to outpatient clinics in
the city.
Clinical and Virological Analysis
During the first 2 mo of pandemic transmission, 2009 H1N1
diagnostics at HTD were performed on 851 patients, comprising
1,537 individual respiratory specimens and 31 rectal swabs. Of
these 851 patients, 292 (34%) were confirmed positive with 2009
H1N1 and are included in the present summary: 195 infected
patients consisted of intercepted travelers transferred to HTD for
follow-up, and 97 were patients diagnosed through the HTD
outpatient clinic or through contact tracing of community
outbreaks. Results of molecular analysis and viral culture are
presented in Figure S1. Among the cohort of 292, the median age
was 26 y (range, 1–72); 193 were men. This discrepancy of male
versus female was caused by an outbreak in a secondary school for
boys (n=50). Fever was present in 96% (n=281), cough in 59%
(171), runny nose in 17% (49), sore throat in 23% (68), and
diarrhea in 2% (5). Influenza-like illness (fever and respiratory
symptoms [ILI]) was noted in 61% (179). Average duration of
fever on presentation was 2 d. After 24 h, 78% (n=228) of
patients had a normal temperature. None of the patients
experienced pneumonia or severe outcomes. One patient had
evidence of infiltration on chest X-ray examination, and all others
(n=291) were normal. There was no marked skewing of the age
distribution of cases or any apparent correlation of clinical or
virological markers by age group. A substantial percentage of
patients (47%, 135/290) presented with mild-to-moderate lym-
phopenia (,1,300/ml). The number of lymphocytes depended
inversely on log Ct value infVA RT-PCR, a surrogate measure of
viral load (p,0.005, linear regression).
Figure 3 presents a summary of the PCR results from
respiratory samples in relation to day of illness and day of
treatment. At day 5 of illness, .50% (48/85) of samples taken
were PCR negative, and at day 9 of illness .90% were negative
(Figure 3A). Similarly, at day 3 of treatment .50% (45/72) of
Table 1. Characteristics of study participants.
Travelers and HCMC residents from whom data were used in this study 27 April–9 July 2009
a 27 April–24 July 2009
Number of passengers arriving at Tan Son Nhat International Airport in HCMC
From all countries 630,778 about 760,000
b
From epidemic countries 361,143 Unknown
c
Number of arriving passengers suspected of influenza, isolated, and monitored 967 Unknown
Number of arriving passengers subsequently determined to be PCR-positive for
2009 H1N1 at HTD laboratories in HCMC
153–166
d 200
e
Number of residents (nontravelers) admitted to hospital with symptoms and tested PCR-
positive for 2009 H1N1
21 121
f
aThe middle column represents the complete dataset of HCMC Health Services reports and HTD’s RT-PCR results. The last available report includes data on passengers
arriving before 13:00 on 9 July 2009. The middle column indicates the number of patients used for epidemiological analysis (Figure 2), and the right column indicates
the number of patients from whom data were available for virological analysis (Figures 3 and 4).
bEstimate of 760,000 passengers based on an average of 8,500 daily international arrivals into Vietnam between 27 April and 9 July 2009.
cDifficult to estimate as definition of ‘‘epidemic countries’’ was changing rapidly at this time.
dThirteen patients with dates of arrival missing were admitted between 9 July and 12 July 2009. They could have landed in HCMC before or after the 9 July 13:00-cutoff
time stated in the last HCMC Health Services report.
e192 of these patients were included in the clinical and virological analysis.
f97 of these patients were included in the clinical and virological analysis.
doi:10.1371/journal.pmed.1000277.t001
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5-d oseltamivir course .90% (167/179) were negative (Figure 3B).
These figures are biased because of different sampling schedules,
and because patients who remained positive were sampled daily,
thus causing a bias towards positivity on ‘‘late’’ sampling days. 14
patients were still PCR-positive 1 d after finishing a 5-d course of
oseltamivir. Prolonged PCR-positivity did not appear to be
correlated with disease severity as no patients had a complicated
course of disease, and the median time-to-fever clearance was 48 h
in both patients who were still positive at day 5 of treatment or
later (n=25) and in patients who were PCR negative at day 5 or
earlier (n=180). All rectal swabs were PCR negative (n=31).
Culture isolation was attempted on a total of 115 PCR-positive
respiratory specimens representing serial samples from 33 patients.
Attempts were especially focused on patients whose PCR results
remained positive after treatment. Isolations were successful from
20 of 33 patients (overall recovery 61%), and cultured virus was
obtained from 38 of the 115 respiratory specimens (33%) (see
Figure 3C and 3D). Culture positivity among PCR positive
samples decreased as day of illness or treatment progressed. No
isolates were recovered from 21 (11 of which were PCR positive)
specimens collected after day 8 of illness or from 29 (16 of which
were PCR positive) specimens collected after day 5 of oseltamivir
treatment. Attempts to quantify live virus directly from respiratory
swabs (days 1 and 2 postadmission) by TCID50 or plaque assays
were unsuccessful, suggesting that levels of virus shedding were
below the limit of detection of our TCID50 and plaque assays (100
plaque-forming units [PFU]/ml).
Figure 4A and 4B shows the maximum and the minimum
number of days of PCR-positivity in our patient set on the basis of
last PCR-positive day and first PCR-negative day for 278 patients
for whom these values, as well as day of treatment initiation, were
available; the inferred maximum-likelihood curve of PCR-
positivity is shown in red. More than 50% of patients had their
last positive RT-PCR by day 3 of illness, and their first negative by
day 7 (.90% by days 7 and 9, respectively). Counting from the
first day of treatment, .50% of patients had their last positive
sample by day 2 of treatment and their first negative by day 5
(.90% by days 5 and 7, respectively). Because patients presented
at HTD with different illness histories, we were able to partially
Figure 2. Status of confirmed new cases in HCMC. 321 PCR-confirmed 2009 H1N1 cases and 298 PCR-negative suspected 2009 H1N1 cases
admitted to hospitals in HCMC between early May 2009 and 20 July 2009. All 619 individuals are classified either as travelers (those who recently
entered HCMC on a commercial flight from a foreign country) or residents; travelers are shown above the axis and residents below the axis. Graph is
organized in a stacked fashion, so that the height of each colored area corresponds to the number of patients of a particular status (e.g., circulating,
isolated) on a particular day. Graph is cut off on 20 July 2009 as the data were more sparse after this date.
doi:10.1371/journal.pmed.1000277.g002
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patients according to their illness-to-treatment intervals (first day of
treatment minus day of illness onset). For patients with illness-to-
treatment intervals of 1 to 4 d, PCR negativity was primarily
determined by day of treatment rather than day of illness. In
contrast, patients with a longer interval cleared virus earlier during
the course of treatment, possibly related to natural course of illness
and immune response (see Figure 4C–4F).
According to the maximum-likelihood curves in Figure 4A, 4B,
4E, and 4F, median time to PCR negativity was 4.9 d after illness
onset (95% CI 4.6–5.1) and 2.6 d after treatment initiation (95%
CI 2.4–2.8). For patients who started treatment the same day as
illness onset, median time to PCR negativity was 2.0 d after start
of treatment (95% CI 1.5–2.5). For patients who started treatment
after illness onset, median times to PCR negativity post-treatment
were 2.8 d (95% CI 2.3–3.2), 2.7 d (95% CI 2.3–3.1), 2.6 d (95%
CI 2.1–3.1), and 2.6 d (95% CI 1.9–3.3), for illness-to-treatment
intervals of 1, 2, 3, and 4 d, respectively.
Samples from 33 patients (n=50) were screened for the
presence of the oseltamivir resistance–associated H275Y mutation
in the neuraminidase gene by real time RT-PCR. Selection of
patients for screening was based on prolonged PCR-positivity
(.5 d), with the caveat that only specimens with significant viral
RNA (Ct value of 38 or less, as determined by InfVA RT-PCR)
were chosen for screening. Phenotypic screening for NAI
resistance by IC50 assay was performed on selected H1N1 isolates
(n=23 specimens, representing 16 patients), and did not yield any
evidence for oseltamivir resistance. To date, samples from three
patients (hospitalized after the described patient group of 292
patients) have tested positive for the H275Y mutation by RT-PCR
and complete sequencing of the NA gene. Specimens collected on
admission showed only wild-type virus; the H275Y mutation was
present in samples taken on or after day 5 of treatment only. The
clinical course of illness in two patients was unremarkable. One
patient, a 3-y-old child, required admission to an intensive care
unit for respiratory support but made a full recovery within 10 d.
No association between emergence of resistance and deterioration
of symptoms were noted.
Discussion
In the 3 mo from 27 April to 24 July 2009, 760,000 passengers
who entered HCMC on international flights were screened for
2009 H1N1 influenza: 0.15% were intercepted, 200 had a positive
2009 H1N1 RT-PCR. An additional 121 out of 169 nontravelers
tested positive after self-reporting or contact tracing. These 321
patients were isolated and treated, and spent 79% of their PCR-
positive days in isolation or under both treatment and isolation
(59.9%). Most patients had mild disease and none experienced
pneumonia or a severe outcome. Viral clearance was similar
among patient groups with different illness-to-treatment intervals,
with an estimated median clearance time of between 2.6 and 2.8 d
after treatment start for intervals of 1–4 d, and 2.0 d when
treatment was started on the first day of illness.
Effectiveness of Isolation Measures
During the documented period of the containment phase (27
April to 9 July 2009) of the epidemic in HCMC, a high percentage
(16%–17%) of intercepted travelers tested positive by RT-PCR for
2009 H1N1 influenza. This number reflects the high levels of
global transmission of the novel pandemic virus and is in the range
of the typical detection of seasonal influenza in influenza-like
illness surveillance programs in the region, usually between 12%
and 25% [16,17]. These levels are, however, not directly
comparable as these surveillance programs use more stringent
definitions than airport screenings. The 200 total positive cases
through 24 July 2009 suggests that more than three symptomat-
ically infected individuals were coming in per day during the 60-d
Figure 3. RT-PCR and culture results related to day of illness or treatment. (A and B) PCR status for 932 individual samples by day of illness
(A) and day of treatment (B), with the vertical axis extending to 292, the number of patients from whom samples were taken. (C and D) 108 (C) and
111 samples (D) of a total of 115 with which viral culture was attempted. Day one of treatment is the day of treatment initiation. Day zero of
treatment is 1 d before treatment is initiated. Three culture-positive samples were PCR-negative: two taken on fourth day of illness (second day of
treatment), and one taken on sixth day of illness (fourth day of treatment).
doi:10.1371/journal.pmed.1000277.g003
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presymptomatic, and hence undetectable, individuals would have
arrived in HCMC during the same time period (assuming a 1-d
incubation period, a 5-d symptomatic period, and that the 200
positive cases were intercepted during the symptomatic period).
The epidemic in HCMC was clearly not containable, a conclusion
easily inferred from previous mathematical analyses [18–20].
Despite the long odds against containment, our analysis
indicates that for the 321 mildly symptomatic to moderately ill
cases identified in HCMC between 31 May and 24 July 2009—a
patient group that represents at least 76% of the documented cases
in HCMC at the time—the majority of PCR-positive days were
spent in isolation (79.0%) or under both treatment and isolation
(59.9%). The containment program of screening, isolating, and
Figure 4. Per patient analysis of RT-PCR results shown by day of illness and day of treatment. Time to PCR negativity and its dependence
on illness-to-treatment interval. (A) Gray lines show the minimum and maximum number of patients who were PCR-negative after a certain number
of days of illness, on the basis of patients’ last positive PCR result and first negative PCR result, which could be separated by a gap of as many as 4 d.
Red line shows the ML-fit (see Methods) of time to PCR negativity, and dashed lines are 95% confidence bands. (B) as (A), related to days of treatment.
(C, D) Minimum and maximum durations of PCR positivity for patient subgroups corresponding to the length of illness-to-treatment interval. (E, F)
ML-curves describing time to PCR-negativity for patient subgroups. Curves for patients who started treatment on the day of illness onset (illness-to-
treatment interval=0, 11 patients), and patients who started treatment 5 d postillness (illness-to-treatment interval=5, 10 patients) are shown in
gray as they differ qualitatively from the other four curves. Legend in (D) applies to (C–F). Data from 278 patients with both negative and positive
PCRs were used to make these graphs.
doi:10.1371/journal.pmed.1000277.g004
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outbreak’s R0 during the initial weeks, although this impact cannot
be assessed quantitatively without knowing the degree of viral
circulation among asymptomatic patients or the health-seeking
behavior of individuals with respiratory symptoms. Reed et al. [21]
suggested that for every reported case in the United States, 79
cases were unreported because of lack of symptoms, care-seeking,
testing, or test sensitivity; 33 unreported cases for every reported
case were estimated from the same data in the early phase of the
epidemic. Even during this early phase in the United States, the
virus was probably already established in the community. In
Vietnam, on the other hand, no imported cases were detected
during airport screening from 27 April to 25 May 2009, and given
the active case finding employed in HCMC during the initial
response, it is not likely that undetected community transmission
at such a scale (multiplier of 33, implying ,10,000 true cases) was
occurring in Vietnam in May or June 2009.
In two European experiences of the early phase of the
pandemic, 97% of all confirmed cases (Germany) and 88% of
nontraveler confirmed cases (The Netherlands) from active case
finding were symptomatic. In The Netherlands, 75 d after the first
imported case, no cases of 2009 H1N1 had been detected in the
sentinel surveillance system, indicating that a significant amount of
asymptomatic community transmission was unlikely during that
time [22,23].
An additional complication when considering a patient group
composed of travelers and residents is that we do not know how,
once infected, the individual threshold for self-reporting to an
outpatient clinic relates to the chance of being intercepted with
symptoms of influenza-like illness at an airport screening, and how
these differences may bias our interpretations of the effectiveness
of control measures. Although we are not able to asses this bias or
the health-seeking behaviors of individuals in HCMC, we are
currently following a cohort of healthy individuals to measure the
degree of asymptomatic 2009 H1N1 circulation. If the asymp-
tomatic fraction turns out to be small or negligible, control
measures may have delayed sustainable community transmission.
If the asymptomatic fraction is large, control measures likely had
no effect.
The intervention strategies put in place in HCMC—airport
screening, isolation, and treatment—shortened the duration of
viral shedding for each detected patient (Figure 4D, 4F, and [24]),
shortened the amount of time each detected patient was
circulating in the community, and increased patients’ likelihood
of hygienic behavior and self-reporting if they had influenza-like
symptoms (17% of incoming international flights were given
announcements suggesting self-quarantine, mask wearing, and
guidelines for monitoring personal health). Certainly, the costs and
benefits of airport screenings must be evaluated in light of the
relative risks of disease introduction as well as the opportunity cost
of concentrating public health resources on slowing the inevitable
importation of one disease. As costs of the containment strategy
are unknown, this is difficult to evaluate. It is important to note
that these data are observational and therefore cannot prove
whether the containment efforts delayed community transmission
in Vietnam.
Clinical and Virological Features
Overall, the observed clinical and virological features of 2009
H1N1 influenza in Vietnam confirm the patterns of mild disease
observed in other affected countries [25,26]. There has been much
interest in estimating viral shedding durations for the new
influenza variant, as these parameters are critical for determining
recommended periods of (self)-isolation, and are key to modeling
transmission dynamics. In our oseltamivir-treated patient group,
we found the time to PCR negativity for the majority of patients
was between 3 and 7 d of illness, and between 1 and 3 d after
treatment initiation. Only 14 patients (4.8%) had a positive PCR
1 d after completing a 5-d course of oseltamivir. These results are
comparable to earlier work on oseltamivir treatment in seasonal
influenza [24,27]. Whitley et al. [27] demonstrated clearance of
viable virus after 4 d of treatment in 45% (42/93) of children
under 12 y, versus 31% (33/105) on placebo, and full culture
negativity by day 6 in both treated and untreated children.
Similarly, in a randomized controlled study of experimentally
infected healthy volunteers infected with seasonal H1N1, Hayden
et al. [24] showed a median duration of viral shedding of 2.4 d
(1.4–2.5 d) in the oseltamivir-treated groups (n=56), and 4.5 d
(1.6–5.4) in the placebo group (n=13). For the 2009 H1N1 virus,
randomized controlled trials have yet to be conducted. However,
data emerging from descriptive studies suggests similar trends.
One report of untreated patients (n=44) in Canada found 43% of
patients remained PCR positive until day 8 postonset [28,29], and
a study from Singapore (n=73) indicated a median shedding time
of 6 d postonset, with 47% still being PCR positive at day 7 [30].
Our data indicate that for illness-to-treatment intervals of 1–4 d,
viral RNA clearance is determined by the duration of treatment
and not by the duration of illness. These data indicate that
oseltamivir provides a consistent shortening in the total duration of
viral shedding when administered at least during the first 4 d of
illness in uncomplicated 2009 H1N1. When given later, viral
shedding times in this infection appear to resemble the natural
course of uncomplicated, untreated seasonal and pandemic 2009
H1N1 illness [24,28,31,32]. Patients in this study were not
randomized, and we cannot rule out any bias in the composition
of our patient population through, for example, the influence of
symptom severity on health-seeking behavior of outpatients or
willingness or ability of infected travelers to board a plane.
Among our patient samples, we were unable to culture virus
from samples taken after 5 d of treatment with prolonged PCR-
positivity (Figure 3), suggesting that although patients may harbor
detectable viral RNA in mucosa, this result may reflect shedding of
replication-incompetent virus. Our results on low concentrations
of culturable virus are supported by the work of Panning et al. [33]
indicating low viral loads in H1N1 specimens (median of 10
4.6
viral RNA copies/ml). Witkop et al. [32] reported a relatively high
percentages of culture positivity among patients in an air force
academy outbreak: 41% (9/22) on day 5 and 24% (7/29) on day 7
of illness compared to 36% (7/19) and 6% (1/16) among our
patients, respectively. Although the percentage of treated patients
among their culture positives was not reported, it is notable that
their percentages are higher than ours because we selectively
attempted culture on samples from patients shedding RNA for a
relatively longer time.
Median estimated viral clearance time in our population was
4.9 d, as compared to 6 d in a recent paper from China describing
426 mild to moderately ill patients infected with 2009 H1N1 [26].
The age distribution among both patient groups was similar. The
observed difference in shedding times may be explained by the fact
that Cao et al. used the first day of PCR negativity to calculate
shedding time (as sampling frequency was not specified, we cannot
be sure of this), whereas we estimated shedding time from all 292
patients including data from 50 patients sampled daily. Another
explanation may be the fact that 82% of patients described by Cao
et al. were treated with oseltamivir, 60% of all patients within 2 d
of illness, whereas in our study 100% of patients received
oseltamivir and 64% within 2 d. Other authors have reported
longer viral shedding times in younger children infected with 2009
2009 H1N1 in Ho Chi Minh City
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5 y, 6 d for children aged 5–9 y, and 5 d for children aged 10 y or
older [31]. No significant differences in viral clearance times
between different age groups were found in our dataset, but our
dataset only included five children aged 10 y or younger.
Selection of resistant viruses during treatment with oseltamivir
was reported to occur at a frequency of 18% (9/50) among H3N2
infected children [34]. Selection of mutants carrying the H275Y
mutation during treatment has been described in 0.5% (n=1/150,
Influenza A) [35], 4% (n=2/54, seasonal H1N1) [36], and 27%
(n=3/11, seasonal H1N1) [37] of treated patients. In our patients,
selection of resistant virus did not appear to be a common event:
among the 33 longest shedders no H275Y mutant virus was found.
We have previously reported on three patients in whom this
mutation was selected during treatment. These patients were
isolated in our hospital later in August and September 2009 [3].
Perspectives
Our data provide insights regarding the efficacy of oseltamivir
treatment in 2009 H1N1 infection. Our study of the situation in
HCMC during the beginning of this outbreak in southern
Vietnam suggests that strict containment measures may have
reduced community exposure of infected patients, which may have
delayed onset of community-based transmission; however they did
not prevent the eventual establishment and widespread circulation
of pandemic influenza in Vietnam. Failure of containment
measures was undoubtedly also due to substantial numbers of
imported cases, both symptomatic and asymptomatic, that
inevitably escaped detection at airport screenings.
Our dataset is neither complete nor comprehensive, but
establishing a systematic and comprehensive sampling scheme
and collecting a complete dataset requires time to obtain ethical
approval, which was impossible given the rapid response that was
required for this unexpected event. We have, however, begun a
descriptive clinical trial on oseltamivir treatment of 2009 H1N1
patients starting 12 August 2009, which includes systematic daily
sampling using RT-PCR, viral culture, and pharmacokinetic
analysis (NCT00985582). Additional future studies to improve
understanding of post-pandemic influenza dynamics should focus
on demographic shifts in infection patterns [38], the accumulation
of herd immunity and the generation of the first escape mutants
[39], the risks of the human–animal interface in regions
experiencing high levels of endemic transmission [40], competition
and displacements patterns between 2009 H1N1 and seasonal
H1N1 and H3N2 viruses, and potential virulence changes in the
new virus.
Supporting Information
Figure S1 RT-PCR and culture results for 2009 H1N1
confirmed patients per day of illness. X indicates no PCR was
done on that day, + indicates a positive result, 2 indicates a
negative result. Fills indicate if culture was done, green indicates
culture was negative, orange indicates culture was positive. Thick
black borders surround the days that pateints received oseltamivir,
red borders indicate zanamivir treatment.
Found at: doi:10.1371/journal.pmed.1000277.s001 (0.14 MB
XLS)
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Background. Every year, millions of people catch
influenza—a viral infection of the airways—and about half
a million people die as a result. These yearly seasonal
epidemics occur because small but frequent changes in the
influenza virus mean that the immune response produced by
infection with one year’s virus provides only partial
protection against the next year’s virus. Sometimes,
however, a very different influenza virus emerges to which
people have virtually no immunity. Such viruses can start
global epidemics (pandemics) and can kill millions of people.
Consequently, when the first case of influenza caused by a
new virus called pandemic A/H1N1 2009 (2009 H1N1, swine
flu) occurred in March 2009 in Mexico, alarm bells rang.
National and international public health agencies quickly
issued advice about how the public could help to control the
spread of the virus and, as the virus spread, some countries
banned flights from affected regions and instigated
screening for influenza-like illness at airports. However,
despite everyone’s efforts, the virus spread rapidly and on
June 11, 2009 the World Health Organization (WHO) declared
that an influenza pandemic was underway.
Why Was This Study Done? To date, little is known about
the spread of and response to 2009 H1N1 in tropical
countries. In this study, therefore, the researchers investigate
the early progression of the 2009 H1N1 pandemic in Ho Chi
Minh City, Vietnam, and the treatment of infected patients.
On April 27, 2009, when WHO announced that human-to-
human transmission of 2009 H1N1 was occurring, the
Vietnamese Ministry of Health mandated airport body
temperature scans and symptom questionnaire screening
of travelers arriving in Vietnam’s international airports.
Suspected cases were immediately transferred to in-
hospital isolation, screened for virus using a sensitive test
called PCR, and treated with the anti-influenza drug
oseltamivir if positive. The first case of 2009 H1N1 infection
in Vietnam was reported on May 31, 2009 in a student who
had returned from the US on May 26, 2009, and, despite
these efforts to contain the infection, by the second half of
July the virus was circulating in Ho Chi Minh City (community
transmission).
What Did the Researchers Do and Find? The researchers
used reports from the Ministry of Health and relevant health
authorities and clinical and laboratory data for people
infected with 2009 H1N1 and isolated in hospital to
reconstruct the initial outbreak and the establishment of
community transmission in Ho Chi Minh City. Between April
27 and July 24 2009, three-quarters of a million passengers
arriving in the city on international flights were screened at
the airport. 200 passenger tested positive for 2009 H1N1 as
did 121 nontravelers who were identified during this period
after self-reporting illness or through contact tracing. The
infected individuals spent 79% of the days when they tested
positive for 2009 H1N1 by PCR (days when they were
infectious) in isolation; 60% of their PCR-positive days were
spent in isolation and treatment. Importantly, travelers and
nontravelers spent 10% and 42.2%, respectively, of their
potentially infectious time in the community. None of the
patients became severely ill but 61% experienced an
influenza-like illness. Finally, the average time from starting
treatment to clearance of the virus was between 2.6 and 2.8
days for patients who began treatment 1 to 4 days after
becoming ill; for those who started treatment on the first day
of illness, the average virus clearance time was 2.0 days.
What Do These Findings Mean? These findings, although
limited by missing data, suggest that the strict containment
measures introduced early in the 2009 H1N1 pandemic in Ho
Chi Minh City may have reduced the circulation of infected
people in the community. This reduction in circulation might
have delayed the onset of community transmission, suggest
the researchers, but because the study was observational,
this possibility cannot be proven. However, importantly,
these findings show that the containment measures were
unable to prevent the eventual establishment of pandemic
influenza in Vietnam, presumably because many imported
cases were not detected by airport screening. Finally, these
findings suggest that in Vietnam, as in other countries, 2009
H1N1 causes a mild disease and that this disease responds
quickly to treatment with oseltamivir whenever treatment is
started in relation to the onset of illness.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000277.
N The US Centers for Disease Control and Prevention
provides information about influenza for patients and
professionals, including specific information on H1N1
influenza and how to prevent its spread
N Flu.gov, a US government website, provides information
on H1N1, avian, and pandemic influenza
N The World Health Organization provides information on
seasonal influenza and has detailed information on H1N1
influenza (in several languages); the WHO Representative
Office in Vietnam provides an overview of the current 2009
H1N1 situation in Vietnam
N The UK Health Protection Agency provides information on
pandemic influenza and on H1N1 influenza
N Wikipedia has a timeline of the 2009 H1N1 pandemic (note
that Wikipedia is a free online encyclopedia that anyone
can edit; available in several languages)
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